Tetsuya Taga
#114,967
Most Influential Person Now
Researcher
Tetsuya Taga's AcademicInfluence.com Rankings
Tetsuya Tagacomputer-science Degrees
Computer Science
#4463
World Rank
#4706
Historical Rank
Computational Linguistics
#433
World Rank
#440
Historical Rank
Machine Learning
#880
World Rank
#892
Historical Rank
Artificial Intelligence
#1091
World Rank
#1110
Historical Rank
Download Badge
Computer Science
Tetsuya Taga's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Tetsuya Taga Influential?
(Suggest an Edit or Addition)Tetsuya Taga's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin (1986) (2056)
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas (1988) (1730)
- Gp130 and the interleukin-6 family of cytokines. (1997) (1547)
- Interleukin-6 in biology and medicine. (1993) (1397)
- Structure and function of a new STAT-induced STAT inhibitor (1997) (1366)
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 (1989) (1353)
- Interleukin-6 family of cytokines and gp130. (1995) (1343)
- Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) (1990) (1322)
- Molecular cloning and expression of an IL-6 signal transducer, gp130 (1990) (1181)
- Biological and clinical aspects of interleukin 6. (1990) (1074)
- Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. (2004) (1022)
- Cytokine signal transduction (1994) (986)
- Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. (1988) (943)
- Interleukin-6 and its receptor: a paradigm for cytokines. (1992) (879)
- Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. (1999) (847)
- Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. (1993) (832)
- Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. (1994) (806)
- IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. (1993) (723)
- CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 (1992) (677)
- Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). (1985) (672)
- Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. (1996) (669)
- LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. (1993) (644)
- Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. (1995) (508)
- DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. (2001) (497)
- AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. (1990) (494)
- Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. (1991) (482)
- Cytokine receptors and signal transduction (1992) (460)
- Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6 (1988) (423)
- Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer (1999) (415)
- Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. (1993) (397)
- BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis (2001) (390)
- Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy (1996) (388)
- Cardiotrophin-1 (1995) (387)
- Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors (1995) (371)
- Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. (1987) (343)
- Developmental Requirement of gp130 Signaling in Neuronal Survival and Astrocyte Differentiation (1999) (325)
- Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma (1996) (319)
- Committed neuronal precursors confer astrocytic potential on residual neural precursor cells. (2009) (317)
- Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. (2001) (310)
- Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. (1994) (299)
- Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. (1992) (290)
- Mesenchymal to Epithelial Conversion in Rat Metanephros Is Induced by LIF (1999) (277)
- Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. (2001) (275)
- Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression (1987) (270)
- Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. (1993) (255)
- BMP2-induced Apoptosis Is Mediated by Activation of the TAK1-p38 Kinase Pathway That Is Negatively Regulated by Smad6* (2000) (249)
- Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130 (1994) (240)
- Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways (1994) (237)
- Postnatally Induced Inactivation of gp130 in Mice Results in Neurological, Cardiac, Hematopoietic, Immunological, Hepatic, and Pulmonary Defects (1998) (226)
- Increased and highly stable levels of functional soluble interleukin‐6 receptor in sera of patients with monoclonal gammopathy (1993) (210)
- Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. (1992) (199)
- Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130. (1993) (195)
- Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor (2004) (191)
- The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures (1996) (190)
- Stabilized β-Catenin Functions through TCF/LEF Proteins and the Notch/RBP-Jκ Complex To Promote Proliferation and Suppress Differentiation of Neural Precursor Cells (2008) (179)
- Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. (1989) (174)
- Essential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression (2005) (169)
- gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. (1995) (165)
- Cancer Stem Cells Persist in Many Cancer Cell Lines (2004) (163)
- Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis (1996) (158)
- Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. (1992) (147)
- Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells. (1996) (146)
- Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures (2003) (139)
- Enhanced gene activation by Notch and BMP signaling cross-talk. (2003) (136)
- Astrocyte differentiation mediated by LIF in cooperation with BMP2 (1999) (135)
- Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. (1998) (134)
- gp130, a Shared Signal Transducing Receptor Component for Hematopoietic and Neuropoietic Cytokines (1996) (130)
- Differential shedding of the two subunits of the interleukin‐6 receptor (1993) (125)
- Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. (1992) (124)
- Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. (1991) (121)
- Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells (1996) (119)
- Potentiation of Astrogliogenesis by STAT3-Mediated Activation of Bone Morphogenetic Protein-Smad Signaling in Neural Stem Cells (2007) (118)
- Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes (1989) (118)
- Serum soluble interleukin‐6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin‐6 signal (1993) (115)
- Role of IL-6 in the neural stem cell differentiation (2005) (110)
- Developmental stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter (2004) (109)
- Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. (1991) (109)
- Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component. (1993) (103)
- Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway (2004) (102)
- Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo (1992) (102)
- Osteoclasts are present in gp130-deficient mice. (1997) (98)
- Signaling mechanisms through cytokine receptors that share signal transducing receptor components. (1995) (97)
- Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells (1996) (92)
- Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis (1990) (89)
- B Cell Growth and Differentiation Factors and Mechanism of B Cell Activation (1984) (87)
- Cytokine regulation of localized inflammation. Induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in inflamed human gingiva. (1991) (86)
- The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. (1997) (85)
- Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). (1988) (83)
- Activation of Canonical Wnt Pathway Promotes Proliferation of Retinal Stem Cells Derived from Adult Mouse Ciliary Margin (2006) (82)
- Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks (2010) (79)
- Effect of B cell differentiation factor (BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines. (1985) (78)
- Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. (1995) (78)
- Cell fate determination regulated by a transcriptional signal network in the developing mouse brain (2005) (76)
- The Role of gp130 in Cerebral Cortical Development: In Vivo Functional Analysis in a Mouse Exo UteroSystem (2002) (75)
- Interleukin 6 and expression of its receptor on epidermal keratinocytes. (1990) (75)
- Mechanisms underlying cytokine-mediated cell-fate regulation in the nervous system (2002) (74)
- The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. (2013) (73)
- Roles of lipid rafts in integrin‐dependent adhesion and gp130 signalling pathway in mouse embryonic neural precursor cells (2004) (73)
- IL-6 receptor and mechanism of signal transduction. (1992) (73)
- Fate alteration of neuroepithelial cells from neurogenesis to astrocytogenesis by bone morphogenetic proteins (2001) (72)
- The molecular biology of interleukin 6 and its receptor. (2007) (70)
- Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II). (1985) (69)
- Spred-2 Suppresses Aorta-Gonad-Mesonephros Hematopoiesis by Inhibiting MAP Kinase Activation (2004) (68)
- Biological and clinical aspects of (1990) (68)
- Characteristic Localization of gpl30 (the Signal‐transducing Receptor Component Used in Common for IL‐6/IL‐11/CNTF/LIF/OSM) in the Rat Brain (1996) (67)
- Signaling crosstalk underlying synergistic induction of astrocyte differentiation by BMPs and IL‐6 family of cytokines (2001) (66)
- STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M (1999) (66)
- A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody. (2001) (64)
- Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease (1996) (63)
- Characterization of glycoconjugate antigens in mouse embryonic neural precursor cells (2005) (62)
- Astrocyte differentiation of fetal neuroepithelial cells involving cardiotrophin-1-induced activation of STAT3. (2001) (61)
- Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. (1992) (61)
- Inhibition of BMP2‐induced, TAK1 kinase‐mediated neurite outgrowth by Smad6 and Smad7 (2001) (61)
- Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain. (2000) (61)
- gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities. (1998) (59)
- Cardiotrophin-like cytokine induces astrocyte differentiation of fetal neuroepithelial cells via activation of STAT3. (2002) (58)
- Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice (2013) (57)
- Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. (1997) (57)
- AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. (1995) (56)
- Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. (1994) (54)
- Overlapping and distinct signals through leptin receptor (OB‐R) and a closely related cytokine signal transducer, gp130 (1997) (54)
- The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. (1996) (54)
- A novel mammalian T-box-containing gene, Tbr2, expressed in mouse developing brain. (1999) (51)
- Cytokine Signal Transduction through a Homo‐or Heterodimer of gp130 (1995) (51)
- Cell density-dependent regulation of hepatic development by a gp130-independent pathway. (2000) (50)
- Astrocyte Differentiation of Fetal Neuroepithelial Cells by Interleukin‐11 via Activation of a Common Cytokine Signal Transducer, gp130, and a Transcription Factor, STAT3 (2000) (49)
- Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. (2006) (46)
- Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling. (1999) (46)
- Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functions. (1993) (44)
- Stage‐ and site‐specific DNA demethylation during neural cell development from embryonic stem cells (2005) (44)
- Glioma Stem Cells (2011) (44)
- Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. (2001) (41)
- Introduction of Human γ1 Immunoglobulin Genes into Fertilized Mouse Eggs (1984) (40)
- IL-6 Receptor (1990) (40)
- Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. (1996) (39)
- Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells. (1992) (39)
- Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation (2017) (39)
- Targeted disruption of the mouse ELYS gene results in embryonic death at peri‐implantation development (2004) (38)
- Identification of a novel transcription factor, ELYS, expressed predominantly in mouse foetal haematopoietic tissues (2002) (37)
- Regulation of Hematopoietic Development in the Aorta-Gonad-Mesonephros Region Mediated by Lnk Adaptor Protein (2003) (37)
- Interleukin 6 and its receptor in the immune response and hematopoiesis. (1990) (37)
- Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130. (1997) (36)
- Glycosphingolipid synthesis inhibitor represses cytokine-induced activation of the Ras-MAPK pathway in embryonic neural precursor cells. (2005) (36)
- Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation. (1992) (36)
- Targeted Disruption of the IL‐6 Related Genes: gp130 and NF‐IL‐6 (1995) (35)
- Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines (1991) (33)
- Interleukin-6 receptor and signals. (1992) (33)
- Ligand recognition by the vitamin D receptor. (2001) (32)
- IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130. (1992) (32)
- Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin‐6 (1997) (32)
- Induction of protumoral CD11chigh macrophages by glioma cancer stem cells through GM‐CSF (2016) (32)
- A multifunctional cytokine (IL-6/BSF-2) and its receptor. (1989) (32)
- Wnt3a Promotes Hippocampal Neurogenesis by Shortening Cell Cycle Duration of Neural Progenitor Cells (2010) (31)
- Molecular Cloning of the cDNAs for Interleukin‐6/B Cell Stimulatory Factor 2 and Its Receptor a (1989) (30)
- A Growth‐Promoting Signaling Component Cyclin D1 in Neural Stem Cells Has Antiastrogliogenic Function to Execute Self‐Renewal (2014) (28)
- Basic fibroblast growth factor endows dorsal telencephalic neural progenitors with the ability to differentiate into oligodendrocytes but not γ‐aminobutyric acidergic neurons (2006) (26)
- Involvement of the Hipk family in regulation of eyeball size, lens formation and retinal morphogenesis (2010) (25)
- gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. (1998) (25)
- gp130, The Cytokine Common Signal-Transducer of Interleukin-6 Cytokine Family, Is Downregulated in T Cells In Vivo by Interleukin-6 (1998) (24)
- A brain region-specific gene product Lhx6.1 interacts with Ldb1 through tandem LIM-domains. (1999) (24)
- Sox17-Mediated Maintenance of Fetal Intra-Aortic Hematopoietic Cell Clusters (2014) (24)
- A Synthetic Polymer Scaffold Reveals the Self‐Maintenance Strategies of Rat Glioma Stem Cells by Organization of the Advantageous Niche (2016) (23)
- Normal and abnormal regulation of human B cell differentiation by a new cytokine, BSF2/IL-6. (1989) (23)
- IL-6 receptor (CD126'IL-6R') expression is increased on monocytes and B lymphocytes in HIV infection. (1998) (22)
- Interleukin-1 (IL-1)-induced IL-6- and IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3',5'-monophosphate-independent signal transduction pathway. (1992) (22)
- Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation. (1997) (22)
- gp130 is involved in stretch-induced MAP kinase activation in cardiac myocytes. (1998) (21)
- Immune and hematopoietic cell regulation: cytokines and their receptors. (1990) (20)
- Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma. (1990) (19)
- Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells (2016) (19)
- Current concepts of B cell modulation. (1989) (18)
- Identification of a novel WD repeat-containing gene predominantly expressed in developing and regenerating neurons. (2000) (18)
- Requirement of gp130 signaling for the AGM hematopoiesis. (2003) (17)
- Increase in GFAP‐positive astrocytes in histone demethylase GASC1/KDM4C/JMJD2C hypomorphic mutant mice (2016) (16)
- gp130 signaling pathways: Recent advances and implications for cardiovascular disease. (1996) (15)
- Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. (1995) (14)
- Cytokines that use gp130 as a signal transducer stimulate mouse placental lactogen-I (mPL-I) but inhibit mPL-II production in vitro. (1995) (14)
- Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes (2016) (14)
- Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments (2020) (14)
- Retinal astrocyte differentiation mediated by leukemia inhibitory factor in cooperation with bone morphogenetic protein 2 (2009) (13)
- Regulation of IL-6 receptor and gp130 expression on human cell lines of lymphoid and myeloid origin. (1992) (13)
- Anti-murine IL-6 receptor antibody inhibits IL-6 effects in vivo. (1991) (13)
- [Roles of BMP in the development of the central nervous system]. (2006) (12)
- Potentiation of Astrogliogenesis by STAT 3-Mediated Activation of Bone Morphogenetic Protein-Smad Signaling in Neural Stem Cells † (2007) (11)
- Glioma stem cell (GSC)‐derived autoschizis‐like products confer GSC niche properties involving M1‐like tumor‐associated macrophages (2020) (11)
- Decidua is a possible source of serum mouse soluble interleukin-6 receptor (msIL-6R): gestational profile of serum msIL-6R concentration. (1994) (11)
- CD45(low)c-Kit(high) cells have hematopoietic properties in the mouse aorta-gonad-mesonephros region. (2012) (11)
- Endomucin is expressed in embryonic dorsal aorta and is able to inhibit cell adhesion. (2001) (10)
- Identification of a population of cells with hematopoietic stem cell properties in mouse aorta-gonad-mesonephros cultures. (2007) (10)
- Osteoclasts are present in gp130-deficient mice. Endocrinology 138: 4959-65 (1997) (9)
- Fate redirection of hippocampal astrocytes toward neuronal lineage by aggregate culture (2005) (9)
- Genomic organization and characterization of the mouse ELYS gene. (2003) (8)
- Genomic organization, sequence and chromosomal localization of the mouse Tbr2 gene and a comparative study with Tbr1. (2000) (8)
- Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues. (2013) (8)
- Inhibition of growth hormone-releasing factor production in mouse placenta by cytokines using gp130 as a signal transducer. (1995) (8)
- Interleukin-6 receptor and a unique mechanism of its signal transduction. (1989) (8)
- Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. (1984) (8)
- Identification of a yolk sac cell population with hematopoietic activity in view of CD45/c‐Kit expression (2011) (7)
- Interleukin‐6 inhibits the chemotaxis of human malignant plasma cell lines (1996) (7)
- Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis. (2007) (7)
- The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G (1999) (6)
- Thrombopoietin contributes to the formation and the maintenance of hematopoietic progenitor‐containing cell clusters in the aorta‐gonad‐mesonephros region (2017) (6)
- Maintenance of hematopoietic stem and progenitor cells in fetal intra‐aortic hematopoietic clusters by the Sox17‐Notch1‐Hes1 axis (2018) (6)
- BSF-2/IL-6 is an autocrine growth factor for human multiple myeloma (1988) (6)
- Sox17 as a candidate regulator of myeloid restricted differentiation potential (2014) (5)
- YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer (2021) (5)
- ONE-POT SYNTHESIS OF 2-SUBSTITUTED 3-TRIFLUOROMETHYL-3-HYDROXY-1,2-BENZISOTHIAZOLE 1,1-DIOXIDES FROM N-SUBSTITUTED BENZENESULFONAMIDES (1998) (5)
- Cells with hematopoietic activity in the mouse placenta reside in side population (2010) (5)
- Myocardial, Hematological, and Placental Disorders Caused by Targeted Disruption of gp130, A Common Signal Transducer for IL-6 Family of Cytokines (1998) (5)
- [Identification of cancer stem cells in the "side population"]. (2006) (5)
- Analysis o f Interleukin 6 Receptor and gp 130 Expressions and Proliferative Capability o f Human CD 34 + Cells (2003) (4)
- [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems]. (1992) (4)
- Regulation of mouse soluble interleukin-6 receptor secretion by decidua. (1995) (4)
- Interleukin 6 (BSF2/IL-6) is an autocrine growth factor for human multiple myelomas. (1988) (4)
- Sox17-mediated expression of adherent molecules is required for the maintenance of undifferentiated hematopoietic cluster formation in midgestation mouse embryos. (2020) (4)
- Interleukin 6 and Its Receptor in Immune Regulation (1989) (4)
- Mediated Release of Human Chorionic Gonadotropin by Choriocarcinoma Cell Lines (Jar and HCCM-5) Activates Adenosine 3',5'-Monophosphate-Independent Signal (1992) (3)
- Report on STAP Cell Research Paper Investigation (2014) (3)
- The Cytokine Common Signal-Transducer of Interleukin-6 Cytokine Family , Is Downregulated in T Cells In Vivo by Interleukin-6 By (1998) (3)
- Regulation of Human B Cell Differentiation: Molecular Structure and Immunological Functions of Human B Cell Differentiation Factor (BSF-2) (1986) (3)
- Up-regulation of lymphocyte antigen 6 complex expression in side-population cells derived from a human trophoblast cell line HTR-8/SVneo (2015) (3)
- Roles of gp130 signaling pathways in cardiac myocytes: recent advances and implications for cardiovascular disease. (1996) (3)
- Molecular structure and immunological function of human B cell differentiation factor (BSF2) (1987) (3)
- Media conditioned by retinal pigment epithelial cells suppress the canonical Wnt pathway (2007) (3)
- Sry-related High Mobility Group Box 17 Functions as a Tumor Suppressor by Antagonizing the Wingless-related Integration Site Pathway (2020) (2)
- Molecular structure of interleukin 6 receptor. (1988) (2)
- Cancer ego-system in glioma: an iron-replenishing niche network systemically self-organized by cancer stem cells (2022) (2)
- gp130, common signal transducer for cytokines including IL-6 (1993) (2)
- [Roles of GSK3beta signaling in the self-renewal of neural progenitor cells]. (2014) (2)
- Regulation of growth and differentiation of human B cells (1985) (2)
- An IL-6 receptor antagonist for IL-6 activity on human myeloma cells (1994) (1)
- Preferential differentiation of neural progenitor cells into the glial lineage through gp130 signaling in N-methyl-d-aspartate-treated retinas (2005) (1)
- Tumor Stem Cells: CD133 Gene Regulation and Tumor Stemness (2012) (1)
- Ex Vivo Expansion of Human Primitive Hemopoietic Progenitors (1996) (1)
- Cellular and Molecular Mechanisms of Human B-Lymphocyte Differentiation (1987) (1)
- Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas (2022) (1)
- Negative regulation of hematopoiesis by the fused in myeloproliferative disorders gene product. (2004) (1)
- [Expression of SSEA-1 in the developing brain]. (2003) (1)
- Continuous activation of gpl 30 , a signal-transducing receptor component for interleukin 6-related cytokines , causes myocardial hypertrophy in mice ( interleukin 6 receptor ) (2005) (1)
- O9. Cross-talk between growth and differentiation pathways in cell fate determination in the developing brain (2010) (1)
- Physiological and pathological role of gp130, a common signal transducer for IL-6-family of cytokines (1996) (1)
- [Cytokines and receptors--their functions, structures and cloning of code genes. Functional polymorphism of BSF-2/IL-6 and its abnormal expression]. (1988) (1)
- Glioma cells remotely promote erythropoiesis as a self‐expanding strategy of cancer stem cells (2021) (1)
- Differentiation of Fetal Brain-derived Neural Precursors Co-cultured with Neonatal Retinal Cells (2003) (0)
- Glycogen synthase kinase 3β has a kinase-independent function in neuronal migration during corticogenesis (2014) (0)
- Involvement of transcription factor Sox17-mediated expression of adhesion molecules in hematopoietic cell cluster formation in midgestation mouse dorsal aorta (2016) (0)
- Hematopoiesis/early commitment (PP-011) (2010) (0)
- Analysis of glial cell sub-lineages in the developing central nervous system using GFAP/Cre-reporter mouse system (2010) (0)
- Up-regulation of lymphocyte antigen 6 complex expression in side-population cells derived from a human trophoblast cell line HTR-8/SVneo (2015) (0)
- Effects of Nonsteroidal Anti–Inflammatory Drug on Differentiation of Neural Progenitor Cells in the Diseased Retinas (2005) (0)
- MASASHI NARAZAKI*, BRUCE A. WITTHUHNt, KANJI YOSHIDA*, OLLI SILVENNOINENt, KIYOSHI YASUKAWAt, (2016) (0)
- Identification and characterization of HTR-8/SVneo SP cells (2014) (0)
- Cell fate determination in the central nervous system governed by a cytokine-mediated transcriptional network and epigenetic DNA modification (2004) (0)
- Epigenetic mechanism conferring astrocytic potential on neural precursor cells (2009) (0)
- Interleukin ( IL )-6 Induc t ion o f Osteoclast Dif ferent iat (2003) (0)
- Inactivation of glycogen synthase kinase 3b links proliferation and self-renewal of telencephalic neuroepithelial cells (2006) (0)
- Retinal Glia Differentiation Mediated by LIF in Cooperation with BMP2 (2003) (0)
- Wnt3a promotes proliferation of retinal progenitor cells (2004) (0)
- Conditional inactivation of gp130 in mice (1997) (0)
- Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production ( B-cell stimulatory factor 2 / NH 2-terminal sequence / cardiac myxoma / autoimmunity ) (0)
- The mechanism of maintaining the undifferentiated state of hematopoietic stem cell by Sox17 and TET family members. (2017) (0)
- Organization of self-advantageous niche by neural stem/progenitor cells during development via autocrine VEGF-A under hypoxia (2023) (0)
- [Cancer stem cells in cancer cell lines]. (2005) (0)
- Molecular mechanism underlying cyclin D1 mediated inhibition of astrocyte differentiation from neural stem/progenitor cells (2010) (0)
- Analysis of STAT3 serine-kinase activated by IL-6 family of cytokines (1998) (0)
- A role of gp130–stimulating cytokines in retinal glial cell differentiation. (2004) (0)
- Molecular Structure o f Interleukin 6 Receptort (2006) (0)
- lymphoma-derived T-cell line ( KT-3 ) Interleukin-6 ( B-cell stimulatory factor 2 )-dependent growth of a Lennert ' s (2005) (0)
- Therapy-resistant nature of cancer stem cells in view of iron metabolism (2022) (0)
- One-Pot Synthesis of 2-Substituted 3-Trifluoromethyl-3-hydroxy-1,2-benzisothiazole 1,1-Dioxides from N-Substituted Benzenesulfonamides. (2010) (0)
- gp130 Signaling Complex Formation Analysed by Single Fluorophore Dynamic Imaging:Its Interaction with Actin Filament (2001) (0)
- Interleukin 6 and its Receptor: Pathological Role in Autoimmunity and Lymphoid Malignancy (1989) (0)
- Maintenance of hematopoietic stem and progenitor cell phenotype of intra-aortic cell clusters in the AGM region through the Sox17-Notch1-Hes1 axis (2015) (0)
- Characterization of Hematopoietic Stem/Progenitor Property of Cells in the Culture of the Mouse Aorta-Gonad-Mesonephros Region. (2005) (0)
- Development, cell lineage and differentiation (2004) (0)
- Interleukin 6 and its receptor: A cytokine acting in the nervous system (1989) (0)
- Structureandfunctionofanew STAT-induced STAT inhibitor (1997) (0)
- Regulation of human B lymphocytes differentiation: Characterization of B cell stimulatory factors (1985) (0)
- Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments (2020) (0)
- Kaposi sarcoma-derived cells produce and respond to interleukin 6 ( proliferation / autocrine growth factor / paracrine growth factor / interleukin-6 receptor / endothelial cells ) (0)
- Regulation of neural stem cells during development and regeneration of the central nervous system (2005) (0)
- Synthetic polymer-based approach revealed an adaptive capacity of glioma stem cells by inducing tumor-infiltrating and iron-accumulating macrophages (2015) (0)
- Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes (2016) (0)
- Cytokine Requirement For The Growth and Differentiation Of Rat Dendritic Cell (DC) Precursors With In Vitro Bone Marrow Cell Cultures (1999) (0)
- transient inhibition of an adaptor protein, Lnk Enhanced engraftment of hematopoietic stem/progenitor cells by the (2011) (0)
- Fetal Hematopoietic Development in the Mouse Aorta-Gonad-Mesonephros Region Is Inhibited by Homeodomain-Interacting Protein Kinase 2. (2005) (0)
- Expression of nervous tissue–specific proteoglycans in the retina after transplantation of neural precursor cells. (2004) (0)
- [Molecular basis of cell fate regulation in the central nervous system]. (2008) (0)
- Molecular cloning of the cDNA encoding human B cell stimulatory factor 2 receptor (BSF-2/IL-6R) (1988) (0)
- A Sox17 downstream gene Rasip1 is involved in the hematopoietic activity of intra-aortic hematopoietic clusters in the midgestation mouse embryo (2022) (0)
- 8 Glioma Stem Cells (2012) (0)
- Report on Review of Appeal of STAP Cell Research Paper Investigation Results (2014) (0)
- SOX17 is critical for the maintenance of stem cell phenotype of intra-aortic hematopoietic clusters of cells in the aorta-gonad-mesonephros region (2015) (0)
- The Expression Pattern of HIPK2 During Mouse Eye Development (2005) (0)
- HIPKs Are Involved in Regulation of Retinal Cell Number and Lens Morphology (2006) (0)
- Retinal Transplantation of Neural Precursor Cells and Their Gene-Modification (2003) (0)
- O-28 Involvement of gp130 in the histogenesis of the cerebral cortex in developing mice (2002) (0)
- Localization of gp130 (the signal transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OM) in the rat brain (1994) (0)
- The immunobiology of interleukin 6 (IL-6) and its receptor (1990) (0)
- BFGF endows dorsal telencephalic neural progenitors with ability to differentiate into oligodendrocytes but not GABAergic neurons (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Tetsuya Taga?
Tetsuya Taga is affiliated with the following schools:
